Get the Stockscreener App
232.26
0.63%
0.76
Overview
News
Price History
Option Chain
Financials
Why ABBV Down?
Discussions
Forecast
Dividend History
Abbvie Inc stock is traded at $232.26, with a volume of 4.51M.
It is up +0.63% in the last 24 hours and up +8.68% over the past month.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
See More
Previous Close:
$231.50
Open:
$232.655
24h Volume:
4.51M
Relative Volume:
0.70
Market Cap:
$410.30B
Revenue:
$61.16B
Net Income/Loss:
$4.20B
P/E Ratio:
98.12
EPS:
2.3671
Net Cash Flow:
$19.68B
1W Performance:
+4.73%
1M Performance:
+8.68%
6M Performance:
+12.71%
1Y Performance:
+20.79%
1-Day Range:
$231.19
$235.25
1-Week Range:
$218.05
$235.25
52-Week Range:
$164.39
$244.81
Abbvie Inc Stock (ABBV) Company Profile
Name
Abbvie Inc
Sector
Industry
Phone
(847) 932-7900
Address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV vs LLY, JNJ, AZN, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
232.15 | 409.15B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
LLY
Lilly Eli Co
|
1,038.20 | 981.09B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.57 | 586.69B | 94.19B | 26.80B | 19.70B | 11.05 |
|
AZN
Astrazeneca Plc
|
210.56 | 318.66B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
166.34 | 311.22B | 54.72B | 14.02B | 15.32B | 7.1855 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-07-26 | Resumed | UBS | Neutral |
| Dec-10-25 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Nov-04-25 | Downgrade | DZ Bank | Buy → Hold |
| Oct-14-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-01-25 | Downgrade | HSBC Securities | Buy → Hold |
| Sep-17-25 | Upgrade | Berenberg | Hold → Buy |
| Aug-12-25 | Resumed | Piper Sandler | Overweight |
| Aug-07-25 | Upgrade | Daiwa Securities | Neutral → Outperform |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Dec-05-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Nov-22-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Nov-04-24 | Upgrade | Argus | Hold → Buy |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Jun-05-24 | Upgrade | HSBC Securities | Hold → Buy |
| May-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-29-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-18-23 | Downgrade | HSBC Securities | Buy → Hold |
| Dec-11-23 | Upgrade | Goldman | Neutral → Buy |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Oct-30-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Resumed | UBS | Neutral |
| Sep-29-23 | Initiated | Raymond James | Outperform |
| Jul-25-23 | Initiated | William Blair | Mkt Perform |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Apr-05-23 | Downgrade | Argus | Buy → Hold |
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Feb-22-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-10-23 | Upgrade | SVB Securities | Underperform → Market Perform |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Nov-08-22 | Downgrade | Societe Generale | Buy → Hold |
| Aug-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-23-22 | Initiated | SVB Leerink | Underperform |
| May-06-22 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Apr-06-22 | Resumed | Morgan Stanley | Overweight |
| Feb-28-22 | Downgrade | UBS | Buy → Neutral |
| Feb-03-22 | Reiterated | BMO Capital Markets | Outperform |
| Feb-03-22 | Reiterated | Barclays | Equal Weight |
| Feb-03-22 | Reiterated | BofA Securities | Neutral |
| Feb-03-22 | Reiterated | Goldman | Neutral |
| Jan-13-22 | Initiated | Redburn | Buy |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-09-21 | Resumed | Wells Fargo | Overweight |
| Nov-23-21 | Upgrade | Societe Generale | Hold → Buy |
| Jul-27-21 | Resumed | Truist | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-23-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jun-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Upgrade | Argus | Hold → Buy |
| May-18-20 | Resumed | BofA/Merrill | Neutral |
| May-12-20 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-20 | Resumed | Morgan Stanley | Overweight |
| Apr-20-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-23-20 | Downgrade | Societe Generale | Buy → Hold |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-26-19 | Reiterated | Cowen | Outperform |
| Sep-26-19 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jun-27-19 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-26-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-28-19 | Initiated | Goldman | Neutral |
| Apr-29-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
View All
Abbvie Inc Stock (ABBV) Latest News
Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell - TradingView
HSBC Adjusts Price Target on AbbVie to $275 From $265, Maintains Buy Rating - marketscreener.com
AbbVie Down Since Q4 Earnings Report: How to Play the Stock - Yahoo Finance
AbbVie Inc. $ABBV Shares Bought by NEOS Investment Management LLC - MarketBeat
Skandinaviska Enskilda Banken AB publ Has $219.56 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Colrain Capital LLC - MarketBeat
Cardano Risk Management B.V. Boosts Stake in AbbVie Inc. $ABBV - MarketBeat
Glenview Trust Co Has $95.89 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Arvest Bank Trust Division Cuts Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie: Dominating Immunology While Building Oncology Upside (NYSE:ABBV) - Seeking Alpha
AbbVie stock: ABBV heads into Tuesday restart after $231.50 close as Botox pricing fight lingers - Bez Kabli
AbbVie Inc. $ABBV Stake Cut by Zions Bancorporation National Association UT - MarketBeat
AbbVie Inc. $ABBV Shares Sold by M&G PLC - MarketBeat
Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider - GlobeNewswire Inc.
AbbVie Inc. $ABBV Position Boosted by Southeast Asset Advisors LLC - MarketBeat
Mmbg Investment Advisors CO. Has $3.96 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Vanguard Group Inc. Acquires 448,554 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Conference: Year-End HS Readouts, SubQ SKYRIZI Data and New IBD Combo Roadmap in Focus - Yahoo Finance
AbbVie Inc. $ABBV Shares Purchased by Capital Planning Advisors LLC - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Fifth Third Bancorp - MarketBeat
AbbVie Inc. (NYSE:ABBV) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Where is AbbVie Inc. (ABBV) headed according to the Street? - MSN
AbbVie stock ends higher Friday; what traders watch for ABBV after the Presidents Day break - TechStock²
AbbVie Inc. $ABBV Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
Shell Asset Management Co. Trims Stake in AbbVie Inc. $ABBV - MarketBeat
PNC Financial Services Group Inc. Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Investment Partners LTD. Sells 13,247 Shares of AbbVie Inc. $ABBV - MarketBeat
HighTower Advisors LLC Raises Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
GF Fund Management CO. LTD. Purchases 5,709 Shares of AbbVie Inc. $ABBV - MarketBeat
Assetmark Inc. Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
ABN Amro Investment Solutions Has $14.53 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Aberdeen Group plc Sells 67,321 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie’s Botox Lawsuit Puts Medicare Pricing Risks In Focus - Yahoo Finance
AbbVie (ABBV) stock price closes near $232 after immunology pipeline talk — what to watch next week - Bez Kabli
DDD Partners LLC Cuts Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie stock price climbs again after Botox lawsuit; what ABBV traders watch next - Bez Kabli
AbbVie (NYSE:ABBV) Trading 1.8% HigherTime to Buy? - MarketBeat
AbbVie Inc (ABBV) Shares Up 3% on Feb 13 - GuruFocus
AbbVie Advances New Toxin-Based Therapy in Ventral Hernia Trial: What Investors Should Watch - TipRanks
ABBV: Key data for lutikizumab, RINVOQ, and IBD combos will drive next-gen immunology advances - TradingView
AbbVie Deal Crowns 25 Years of Determination; Commercial Leap Is the Next Task, Says Glenn Saldanha - ET Pharma
Where is AbbVie Inc. (ABBV) Headed According to the Street? - Yahoo Finance
Metis Global Partners LLC Has $22.53 Million Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Public Sector Pension Investment Board - MarketBeat
Freemont Management S.A. Trims Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) Shares Up 3%What's Next? - MarketBeat
AbbVie sues US health agency over Botox price controls - marketscreener.com
1 reason I'm never selling AbbVie stock - MSN
AbbVie (ABBV) Challenges HHS Over Botox Medicare Price Negotiati - GuruFocus
AbbVie files lawsuit over selection of Botox for Medicare price negotiations - Seeking Alpha
Varma Mutual Pension Insurance Co Has $61 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Abbvie Inc Stock (ABBV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.91%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):